Member Exclusive News

The week in industry: ‘Outcome-based payment’ could help cancer drugs reach patients sooner

This week: The US FDA has approved an sNDA for CINVANTI®, Cell Medica receive US $8.7 million to develop cancer therapies and an integrin research and development collaboration has been announced

Thumb untitled design
Feb 28, 2019

Please sign in or register for FREE

No comments yet.